Fragmented Adipose Tissue Transplanted to Craniofacial Deformities Induces Bone Repair Associated with Immunoexpression of Adiponectin and Parathyroid Hormone 1-Receptor
Restricted accessOtherFirst published online November, 2013
Fragmented Adipose Tissue Transplanted to Craniofacial Deformities Induces Bone Repair Associated with Immunoexpression of Adiponectin and Parathyroid Hormone 1-Receptor
This study analyzed the influence of autogenous white adipose tissue on bone matrix development in critical-size defects created in rabbit calvaria.
Materials and Methods
A 15-mm-diameter defect was created in the calvaria of 42 rabbits. Twenty-one rabbits were treated with 86 mm3 of immediate transplant of fragmented white subcutaneous adipose tissue (WSAT); the others constituted the control group (sham). The animals were euthanized at 7, 15, and 40 days postsurgery (n = 7), and the histological data were analyzed by histomorphometry and immunohistochemistry using the anti-adiponectin and parathyroid hormone 1-receptor (PTH1R) antibodies.
Results
The calvariae treated with fragmented WSAT demonstrated significant bone formation. These results coincided with the significant presence of immunopositivity to adiponectin and PTH1R in loci, which in turn coincided with the increase in bonelike matrix deposited both in fat tissue stroma and adipocytes' cytoplasm. In contrast, the control group revealed a small amount of bone-matrix deposition and presented scarce PTH1R expression and a lack of immunostain for adiponectin.
Conclusion
These results indicate that transplant of fragmented white subcutaneous adipose tissue may be an alternative to treatment of craniofacial bone deformities because adipose tissue suffers from osseous metaplasia and exhibits immunoexpression of the adiponectin and PTH1R, which are proteins associated with bone metabolism
BernerH.S.LyngstadaasS.P.SpahrA.MonjoM.ThommesenL.DrevonC.A.SyversenU.ReselandJ.E.Adiponectin and its receptors are expressed in bone-forming cells. Bone.2004; 35: 842–849.
2.
BringhurstF.R.PTH receptors and apoptosis in osteocytes. J Musculoskelet Neuronal Interact.2002; 2: 245–251.
3.
CalviL.M.BrombergO.RheeY.WeberJ.M.SmithJ.N.BasilM.J.FrischB.J.BellidoT.Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells. Blood.2012; 119: 2489–2499.
4.
CozzolinoM.DussoA.S.SlatopolskyE.Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol.2001; 12: 2511–2516.
5.
DattaN.S.KolailatR.FiteA.PettwayG.Abou-SamraA.B.Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation. Cell Signal.2010; 22: 457–466.
6.
DattaN.S.SamraT.A.MahalingamC.D.DattaT.Abou-SamraA.B.Role of PTH1R internalization in osteoblasts and bone mass using a phosphorylation-deficient knock-in mouse model. J Endocrinol.2010; 207: 355–365.
7.
De LongW.G.Jr., Einhorn TA, Koval K, McKee M, Smith W, Sanders R, Watson T. Bone grafts and bone graft substitutes in orthopaedic trauma surgery: a critical analysis. J Bone Joint Surg Am.2007; 89: 649–658.
8.
Di CataldoS.FicarraE.AcquavivaA.MaciiE.Automated segmentation of tissue images for computerized IHC analysis. Comput Methods Programs Biomed.2010; 100: 1–15.
9.
DivietiP.P.PTH and osteocytes. J Musculoskelet Neuronal Interact.2005; 5: 328–330.
10.
DivietiP.InomataN.ChapinK.SinghR.JuppnerH.BringhurstF.R.Receptors for the carboxyl-terminal region of pth(1–84) are highly expressed in osteocytic cells. Endocrinology.2001; 142: 916–925.
11.
DragooJ.L.ChoiJ.Y.LiebermanJ.R.HuangJ.ZukP.A.ZhangJ.HedrickM.H.BenhaimP.Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res.2003; 21: 622–629.
12.
FermorB.SkerryT.M.PTH/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats. J Bone Miner Res.1995; 10: 1935–1943.
13.
FraserJ.K.WulurI.AlfonsoZ.HedrickM.H.Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol.2006; 24: 150–154.
FullerK.OwensJ.M.ChambersT.J.Induction of osteoclast formation by parathyroid hormone depends on an action on stromal cells. J Endocrinol.1998; 158: 341–350.
16.
GimbleJ.M.ZvonicS.FloydZ.E.KassemM.NuttallM.E.Playing with bone and fat. J Cell Biochem.2006; 98: 251–266.
17.
GiovaniniA.F.DeliberadorT.M.GonzagaC.C.de Oliveira FilhoM.A.GohringerI.KuczeraJ.ZielakJ.C.de Andrade UrbanC.Platelet-rich plasma diminishes calvarial bone repair associated with alterations in collagen matrix composition and elevated CD34+ cell prevalence. Bone.2010; 46: 1597–1603.
18.
GiovaniniA.F.GonzagaC.C.ZielakJ.C.DeliberadorT.M.KuczeraJ.GoringherI.de Oliveira FilhoM.A.Baratto-FilhoF.UrbanC.A.Platelet-rich plasma (PRP) impairs the craniofacial bone repair associated with its elevated TGF-beta levels and modulates the co-expression between collagen III and alpha-smooth muscle actin. J Orthop Res.2011; 29: 457–463.
19.
GomesS.P.DeliberadorT.M.GonzagaC.C.KlugL.G.OliveiraL.C.UrbanC.A.ZielakJ.C.GiovaniniA.F.Bone healing in critical-size defects treated with immediate transplant of fragmented autogenous white adipose tissue: a histomorphometric and immunohistochemical study. J Craniofac Surg.2012; 23: 1239–1244.
20.
GoudyS.LottD.BurtonR.WheelerJ.CanadyJ.Secondary alveolar bone grafting: outcomes, revisions, and new applications. Cleft Palate Craniofac J.2009; 46: 610–612.
21.
HelderM.N.KnippenbergM.Klein-NulendJ.WuismanP.I.Stem cells from adipose tissue allow challenging new concepts for regenerative medicine. Tissue Eng.2007; 13: 1799–1808.
22.
Jacome-GalarzaC.E.LeeS.K.LorenzoJ.A.AguilaH.L.Parathyroid hormone regulates the distribution and osteoclastogenic potential of hematopoietic progenitors in the bone marrow. J Bone Miner Res.2011; 26: 1207–1216.
23.
JustesenJ.PedersenS.B.StenderupK.KassemM.Subcutaneous adipocytes can differentiate into bone-forming cells in vitro and in vivo. Tissue Eng.2004; 10: 381–391.
24.
KhaterR.AtanassovaP.AnastassovY.PellerinP.Martinot-DuquennoyV.Clinical and experimental study of autologous fat grafting after processing by centrifugation and serum lavage. Aesthetic Plast Surg.2009; 33: 37–43.
25.
LeeN.K.SowaH.HinoiE.. Endocrine regulation of energy metabolism by the skeleton. Cell.2007; 130: 456–469.
26.
LivaoğluM.YavuzE.Soft tissue augmentation with autologous fat graft: the dissected pouch technique. J Cutan Aesthet Surg.2009; 2: 21–25.
27.
MatsubaraF.B.ZanicottiD.G.ZielakJ.C.GiovaniniA.F.GonzagaC.C.de Andrade UrbanC.DeliberadorT.M.Nonprocessed adipose tissue graft in the treatment of dehiscence bone defects in rabbit tibiae: a pilot study. Implant Dent.2012; 21: 236–241.
28.
O'BrienC.A.PlotkinL.I.GalliC.. Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS One.2008; 3: e2942.
29.
Olmsted-DavisE.GannonF.H.OzenM.. Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol.2007; 170: 620–632.
30.
OshimaK.NampeiA.MatsudaM.IwakiM.FukuharaA.HashimotoJ.YoshikawaH.ShimomuraI.Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun.2005; 331: 520–526.
31.
PioszakA.A.XuH.E.2008. Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc Natl Acad Sci U S A.2008; 105: 5034–5039.
32.
PlaceE.S.EvansN.D.StevensM.M.Complexity in biomaterials for tissue engineering. Nat Mater.2009; 8: 457–470.
33.
RickardD.J.WangF.L.Rodriguez-RojasA.M.. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Bone.2006; 39: 1361–1372.
34.
SekiyaH.Mikuni-TakagakiY.KondohT.SetoK.Synergistic effect of PTH on the mechanical responses of human alveolar osteocytes. Biochem Biophys Res Commun.1999; 264: 719–723.
35.
SelimA.A.MahonM.JuppnerH.BringhurstF.R.DivietiP.Role of calcium channels in carboxyl-terminal parathyroid hormone receptor signaling. Am J Physiol Cell Physiol.2006; 291: C114–121.
36.
ShenC.N.BurkeZ.D.ToshD.Transdifferentiation, metaplasia and tissue regeneration. Organogenesis.2004; 1: 36–44.
37.
SlackJ.M.Metaplasia and transdifferentiation: from pure biology to the clinic. Nat Rev Mol Cell Biol.2007; 8: 369–378.
38.
SmithJ.O.AarvoldA.TaytonE.R.DunlopD.G.OreffoR.O.Skeletal tissue regeneration: current approaches, challenges, and novel reconstructive strategies for an aging population. Tissue Eng Part B Rev.2011; 17: 307–320.
39.
ThomasT.The complex effects of leptin on bone metabolism through multiple pathways. Curr Opin Pharmacol.2004; 4: 295–300.
40.
ThorwarthM.WehrhanF.Schultze-MosgauS.WiltfangJ.SchlegelK.A.PRP modulates expression of bone matrix proteins in vivo without long-term effects on bone formation. Bone.2006; 38: 30–40.
YoshizawaT.HinoiE.JungD.Y.KajimuraD.FerronM.SeoJ.GraffJ.M.KimJ.K.KarsentyG.The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J Clin Invest.2009; 119: 2807–2817.
